MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2023 International Congress

    A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…
  • 2023 International Congress

    A retrospective comparison between EMG and US-guided botulinum injections for cervical dystonia

    V. Livneh, A. Socher, M. Cohen, Y. Schechter, I. Israel, T. Gurevic, G. Yahalom (Tel Aviv, Israel)

    Objective: To assess the efficacy and safety of ultrasound-guided (USg) botulinum toxin (BT) injections versus electromyography–guided (EMGg)- BT injections for cervical dystonia. Background: BT is…
  • 2023 International Congress

    Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic

    A. Vijayaraghavan, D. Divya, S. Krishnan (Trivandrum, India)

    Objective: To provide unique data on the common patterns of muscles selected for injection and the time course of benefit and weakness for BoNT injections…
  • 2023 International Congress

    Benefit of multiple incobotulinumtoxinA injections for pain reduction in adults with cervical dystonia: an analysis of pooled data

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess the long-term effects of repeated incobotulinumtoxinA (inco-A) injections on cervical dystonia (CD)-related pain in a pooled analysis of studies in adults with…
  • 2023 International Congress

    New DBS targets for dystonia in thalamus and brainstem

    T. Sanger, J. Maclean, J. Olaya, M. Liker (Orange, USA)

    Objective: Our objective is to describe experience with new targets for deep brain stimulation in children with genetic or acquired dystonias. Background: Although DBS has…
  • 2023 International Congress

    The efficacy of thalamic and pallidal deep brain stimulation rescue leads in dystonic tremor depends on the affected body region – a case series

    S. Paschen, J. Becktepe, M. Hobert, K. Zeuner, A. Helmers, D. Berg, G. Deuschl (Kiel, Germany)

    Objective: We aim to investigate whether the body region affected by dystonic tremor and dystonia is important for target selection. Background: For the treatment of…
  • 2023 International Congress

    Pain reduction in adults with cervical dystonia and moderate or severe baseline pain following repeated injections of incobotulinumtoxinA: an analysis of pooled data from phase 3 and 4 studies

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess pain reduction in incobotulinumtoxinA (incoA)-treated adults with cervical dystonia (CD)-related moderate or severe pain at baseline using pooled data from four phase…
  • 2023 International Congress

    Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm

    M. Hast, A. Kong, S. Desai, S. Syed, J. Holmes (Raleigh, USA)

    Objective: To describe the characteristics of patients with cervical dystonia (CD) or blepharospasm (BLEPH) treated with botulinum toxin (BoNT) in routine care using claims data…
  • 2023 International Congress

    The use of pallidal deep brain stimulation (GPi-DBS) to treat GNAO1 gene associated hyperkinetic syndromes

    A. Costa, D. Oliveira, M. Malaquias, L. Botelho, C. Silva, E. Cunha, V. Sá Pinto, N. Vila-Chã, I. Carrilho, M. Magalhães, A. Mendes (Porto, Portugal)

    Objective: To describe the clinical features and benefits of GPi-DBS approach in two patients with GNAO1 gene mutations to whom several episodes of choreo-dystonia exacerbations…
  • 2023 International Congress

    Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia

    M. Wajid, J. Yu, J. Frey, J. Lopes, A. Dave, L. Kugler, T. Stiep, J. Toledo, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)

    Objective: To assess the therapeutic outcomes of botulinum toxin injections (BoNT) in patients with lower limb dystonia (LLD). Background: BoNT to the affected muscle groups…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley